ArticleTherapeutic advances in gastroenterology2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.
Bénédicte Caron et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it